Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

Monoclonal antibodies (mABs) are safe and effective proteins produced in laboratory that may be used to target a single epitope of a highly conserved protein of a virus or a bacterial pathogen. For this purpose, the epitope is selected among those that play the major role as targets for prevention o...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Susanna, Amirthalingam, Gayatri, Bassetti, Matteo, Blasi, Francesco, De Rosa, Francesco Giuseppe, Halasa, Natasha B., Hung, Ivan, Osterhaus, Albert, Tan, Tina, Torres, Juan Pablo, Vena, Antonio, Principi, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226646/
https://www.ncbi.nlm.nih.gov/pubmed/37256125
http://dx.doi.org/10.3389/fimmu.2023.1162342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226646/
https://www.ncbi.nlm.nih.gov/pubmed/37256125
http://dx.doi.org/10.3389/fimmu.2023.1162342

Ejemplares similares